Cell nucleus directed 2,3,5-triiodobenzoic acid conjugates. 2009

Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
Department of Neuroradiology; University of Tübingen; Hoppe-Seyler-Str.3; 72076 Tübingen, Germany.

Triiodobenzoic acid (TIBA) represents the core structure of most clinically used contrast agents for computed tomography and other X-ray procedures. To construct an intracellular radiopaque contrast agent, TIBA was coupled to various different positively and negatively charged fluorescein iothiocyanate (FITC)-labelled peptides. TIBA coupled to the SV40 T Antigen nuclear localization sequence (NLS) stained 80% of human glioma cells and caused cell death. This occurred with C- or N-terminal binding of TIBA and with the correct or mutant NLS. No cell death and only small numbers of stained cells (below 3 %) were observed after incubation with NLS conjugates lacking TIBA or after incubation with TIBA-conjugates containing a negatively charged polyglutamic acid stretch. TIBA-conjugates containing the Antennapedia-derived cell-penetrating peptide penetratin were only nuclearly taken up when TIBA and FITC were coupled to lysines outside the 16-amino acid peptide sequence. The study shows that intracellular TIBA may have potential as a chemotherapeutic agent rather than a contrast agent.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings
D014283 Triiodobenzoic Acids Triiodo-substituted derivatives of BENZOIC ACID. Triiodobenzoic Acid,Acid, Triiodobenzoic,Acids, Triiodobenzoic
D016650 Fluorescein-5-isothiocyanate Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques. FITC,5-Isothiocyanatofluorescein,Fluorescein (5 or 6)-Isothiocyanate,Fluorescein-5-isothiocyanate Hydrochloride,5 Isothiocyanatofluorescein,Fluorescein 5 isothiocyanate,Fluorescein 5 isothiocyanate Hydrochloride,Hydrochloride, Fluorescein-5-isothiocyanate

Related Publications

Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
May 1972, Journal of pharmaceutical sciences,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
February 1968, Journal of pharmaceutical sciences,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
November 1969, Journal of dairy science,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
April 1949, Plant physiology,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
February 1970, Journal of pharmaceutical sciences,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
May 1971, Journal of pharmaceutical sciences,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
January 1971, Journal of agricultural and food chemistry,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
March 1968, Journal of pharmaceutical sciences,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
November 1974, Journal of pharmaceutical sciences,
Alexander Sturzu, and Ulrich Vogel, and Alireza Gharabaghi, and Alexander Beck, and Hubert Kalbacher, and Hartmut Echner, and Stefan Heckl
September 1969, Bulletin of environmental contamination and toxicology,
Copied contents to your clipboard!